Literature DB >> 35286699

The Immunogenetics of Systemic Sclerosis.

Begüm Ünlü1, Ümit Türsen2, Zeynab Rajabi3, Navid Jabalameli4, Fateme Rajabi4,5.   

Abstract

Systemic sclerosis (SSc) is a rare disease with a prevalence ranging from 7 to 700 cases per million. Like with most autoimmune diseases, both environmental and genetic factors are involved in the pathogenesis of the SSc. Though the incidence of SSc in the family members of those affected and the concordance rate in twins is very low, inheritance is still the strongest risk factor of SSc. Thus, multiple studies have been conducted to identify the genes responsible for this inheritance including candidate gene association studies and genome-wide analyses. Variations and mutations in the genes encoding cytokines, adhesion molecules, and signaling proteins involved in the interaction between endothelial cells, fibroblasts, and immune cells have been found to be associated with SSc susceptibility. In this chapter, these genes and their contribution to the pathogenesis of the SSc are discussed in detail. These genes are categorized into five major groups of HLA genes, genes involved in the innate immune responses, genes affecting adaptive immune responses, genes with a role in the fibrogenesis pathways, and apoptosis, autophagy, and pyroptosis-related genes.
© 2022. Springer Nature Switzerland AG.

Entities:  

Keywords:  Fibrosis; Genetic polymorphisms; Immunogenetics; Susceptibility; Systemic sclerosis

Mesh:

Year:  2022        PMID: 35286699     DOI: 10.1007/978-3-030-92616-8_10

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  280 in total

1.  RhoB controls Akt trafficking and stage-specific survival of endothelial cells during vascular development.

Authors:  Irit Adini; Isaac Rabinovitz; Jing Fang Sun; George C Prendergast; Laura E Benjamin
Journal:  Genes Dev       Date:  2003-11-01       Impact factor: 11.361

2.  Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus.

Authors:  Sulaiman M Al-Mayouf; Asma Sunker; Reem Abdwani; Safiya Al Abrawi; Fathiya Almurshedi; Nadia Alhashmi; Abdullah Al Sonbul; Wafaa Sewairi; Aliya Qari; Eiman Abdallah; Mohammed Al-Owain; Saleh Al Motywee; Hanan Al-Rayes; Mais Hashem; Hanif Khalak; Latifa Al-Jebali; Fowzan S Alkuraya
Journal:  Nat Genet       Date:  2011-10-23       Impact factor: 38.330

3.  Lack of Il12rb2 signaling predisposes to spontaneous autoimmunity and malignancy.

Authors:  Irma Airoldi; Emma Di Carlo; Claudia Cocco; Carlo Sorrentino; Franco Fais; Michele Cilli; Tommaso D'Antuono; Mario Paolo Colombo; Mario Paulo Colombo; Vito Pistoia
Journal:  Blood       Date:  2005-08-04       Impact factor: 22.113

Review 4.  Redox regulation of NLRP3 inflammasomes: ROS as trigger or effector?

Authors:  Justine M Abais; Min Xia; Yang Zhang; Krishna M Boini; Pin-Lan Li
Journal:  Antioxid Redox Signal       Date:  2015-01-19       Impact factor: 8.401

5.  Lack of association of eNOS (G894T) and p22phox NADPH oxidase subunit (C242T) polymorphisms with systemic sclerosis in a cohort of French Caucasian patients.

Authors:  Yannick Allanore; Didier Borderie; Hervé Lemaréchal; Ohvanesse Garabed Ekindjian; André Kahan
Journal:  Clin Chim Acta       Date:  2004-12       Impact factor: 3.786

6.  Association of a functional variant downstream of TNFAIP3 with systemic lupus erythematosus.

Authors:  Indra Adrianto; Feng Wen; Amanda Templeton; Graham Wiley; Jarrod B King; Christopher J Lessard; Jared S Bates; Yanqing Hu; Jennifer A Kelly; Kenneth M Kaufman; Joel M Guthridge; Marta E Alarcón-Riquelme; Juan-Manuel Anaya; Sang-Cheol Bae; So-Young Bang; Susan A Boackle; Elizabeth E Brown; Michelle A Petri; Caroline Gallant; Rosalind Ramsey-Goldman; John D Reveille; Luis M Vila; Lindsey A Criswell; Jeffrey C Edberg; Barry I Freedman; Peter K Gregersen; Gary S Gilkeson; Chaim O Jacob; Judith A James; Diane L Kamen; Robert P Kimberly; Javier Martin; Joan T Merrill; Timothy B Niewold; So-Yeon Park; Bernardo A Pons-Estel; R Hal Scofield; Anne M Stevens; Betty P Tsao; Timothy J Vyse; Carl D Langefeld; John B Harley; Kathy L Moser; Carol F Webb; Mary Beth Humphrey; Courtney Gray Montgomery; Patrick M Gaffney
Journal:  Nat Genet       Date:  2011-02-20       Impact factor: 38.330

7.  IL-1A rs1800587, IL-1B rs1143634 and IL-1R1 rs2234650 polymorphisms in Iranian patients with systemic sclerosis.

Authors:  S Abtahi; A Farazmand; M Mahmoudi; A Ashraf-Ganjouei; A Javinani; B Nazari; H Kavosi; A A Amirzargar; A R Jamshidi; F Gharibdoost
Journal:  Int J Immunogenet       Date:  2015-09-28       Impact factor: 1.466

8.  Cutting edge: role of macrophage migration inhibitory factor in inhibiting NK cell activity and preserving immune privilege.

Authors:  R S Apte; D Sinha; E Mayhew; G J Wistow; J Y Niederkorn
Journal:  J Immunol       Date:  1998-06-15       Impact factor: 5.422

9.  An allograft inflammatory factor 1 (AIF1) single nucleotide polymorphism (SNP) is associated with anticentromere antibody positive systemic sclerosis.

Authors:  F Alkassab; P Gourh; F K Tan; T McNearney; M Fischbach; C Ahn; F C Arnett; M D Mayes
Journal:  Rheumatology (Oxford)       Date:  2007-05-23       Impact factor: 7.580

Review 10.  Direct Inhibition of IRF-Dependent Transcriptional Regulatory Mechanisms Associated With Disease.

Authors:  Aleksandra Antonczyk; Bart Krist; Malgorzata Sajek; Agata Michalska; Anna Piaszyk-Borychowska; Martyna Plens-Galaska; Joanna Wesoly; Hans A R Bluyssen
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.